Methods and compositions of bile acids and salts for reduction of fat
The present invention relates to compositions and methods for treating fat deposit accumulation in a subject. The invention provides a non-surgical method for reducing fat deposits comprising administering an effective amount of a fat-lysing concentration of one or more of cholate and chenodeoxycholate in a pharmaceutically acceptable formulation to the subject in need thereof.
1. A method for the non-surgical removal of a localized fat deposit in a subject having localized fat accumulation, comprising administering to the subject a formulation comprising about 0.5% to about 4% cholate, wherein the formulation has a pH of about 8 or less and the formulation is an aqueous solution comprising a buffer and is free of precipitate or gel form at 25° C.
2. The method of claim 1 , wherein the formulation further comprises chenodeoxycholate.
3. The method of claim 1 , wherein the formulation further comprises an additional active ingredient selected from the group consisting of an anti-inflammatory agent, an analgesic, a dispersion agent, a penetration enhancer, and a combination thereof.
4. The method of claim 1 , wherein the formulation further comprises a therapeutic agent selected from the group consisting of an anti-microbial agent, an anti-thrombotic agent, an anti-coagulation agent, a suds-depressant, an anti-inflammatory agent, an anesthetic, an analgesic, a steroid, a tranquilizer, an anti-dispersion agent, a muscle relaxant, and a combination thereof.
5. The method of claim 1 , wherein the formulation is administered by a subcutaneous injection.
6. The method of claim 1 , wherein the localized fat accumulation is selected from the group consisting of lower eyelid fat herniation, lipomas, lipodystrophy, fat deposits associated with cellulite, and a combination thereof.
7. The method of claim 1 , wherein the fat deposit is localized in an area of a subject selected from the group consisting of under eye, under chin, under arm, buttock, calf, back, thigh, ankle, stomach, and a combination thereof.
8. The method of claim 1 , wherein the formulation is in an injectable formulation.
9. The method of claim 1 , wherein the formulation is in a lipolysis injection formulation.
10. The method of claim 1 , wherein the formulation has a pH of about 7 to about 8.
11. The method of claim 1 , wherein the formulation has a pH of about 7.5 to about 8.
12. The method of claim 1 , wherein the formulation has a pH of about 7 to about 7.5.